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Microbial contamination of pharmaceutical products and personal care products (PPCPs) pose a health threat for people with diseases that compromise their immune system, including cystic fibrosis (CF) patients ([@B1], [@B2]). In North America, the most common objectionable microorganism recovered during PPCP recalls are *Burkholderia cepacia* complex (BCC) bacteria ([@B2], [@B3]), which are resistant to most antibiotics and cause infections in CF patients ([@B4], [@B5]).

*Burkholderia contaminans* ([@B6]) is an emerging species of the BCC in CF infections. *B. contaminans* is prevalent in Argentina ([@B7]) and Portugal ([@B8]) and is being increasingly isolated in CF patients from Spain ([@B9]) and Ireland ([@B10]). *B. contaminans* has been linked to outbreaks due to contaminated pharmaceutical products ([@B11], [@B12]). Genome sequences of *B. contaminans* isolated from an Argentinian CF patient ([@B13]) and from soil ([@B14]) have been reported; however, there are no genomic data of isolates obtained from PPCPs. Thus, genome sequence analysis is expected to shed light on whether *B. contaminans* has an enhanced capacity to survive in harsh environments and harbors genetic elements coding for virulence factors. Here, we used Illumina sequencing to obtain a draft genome of *B. contaminans* FFI-28, a strain isolated in Argentina from a pharmaceutical solution.

Cultures were grown in LB, and genomic DNA was isolated using phenol-chloroform as per Sambrook et al. ([@B15]). The isolated genomic DNA was converted into a sequencing-ready library using the Nextera XT DNA sample preparation kit (Illumina). Illumina sequencing was performed in a MiSeq personal sequencing system at the Next Generation Sequencing Core Platform at the Manitoba Institute for Children's Health.

The average genome coverage was 34×. Sequenced reads were merged using FLASH version 1.3.0 ([@B16]) and assembled *de novo* using the SPAdes assembler version 1.2 ([@B17]). The assembly of FFI-28 generated 239 contigs greater than 1,000 bp with a mean contig length of 35,018 bp and an *N*~50~ of 72,119 bp. The predicted genome size was 8.37 Mb with a GC content of 66.3. Species in the genus *Burkholderia* are known for having large multipart genomes, and the sizes of our assemblies fell within the range of 7.4 to 9.73 Mb seen in previously sequenced genomes ([@B18]). Annotation of the assemblies with RAST ([@B19]) identified 7,744 open reading frames, which fall within the range previously seen in BCC genomes.

To classify *B. contaminans* FFI-28 according to multilocus sequence typing (MLST) ([@B20]), we retrieved the sequences of *recA*, *atpD*, *gltB*, *lepA*, *phaC*, *trpB*, and *gyrB* alleles and compared them with those of the BCC MLST website (<http://pubmlst.org/bcc>). The analysis classified *B. contaminans* FFI-28 as belonging to the globally distributed sequence type 102 ([@B21]). This genomic resource provides a starting point for elucidating the role of contaminated PPCPs as a source of infection with an emerging BCC pathogen.
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The *B. contaminans* FFI-28 draft genome has been deposited at DDBJ/ENA/GenBank under the accession number [MDUI00000000](http://www.ncbi.nlm.nih.gov/nuccore/MDUI00000000). The version described in this paper is the first version, MDUI01000000.
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